| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 01/19/2000 | CN1241441A Tolerant Chinese medicine preparation for treating leukemia |
| 01/19/2000 | CN1241439A Gastric cancer treating Chinese medicine preparation |
| 01/19/2000 | CN1241438A Lung cancer treating Chinese medicine preparation and its preparation |
| 01/19/2000 | CN1241408A Medicine with wild cottonrose hibiscus |
| 01/19/2000 | CN1048495C Tetrahydropyran derivatives, its producing process and their medical composition containing them |
| 01/19/2000 | CN1048493C O6-substituted guanine derivatives, a process for their prepn. and their use |
| 01/19/2000 | CN1048490C Cyclic derivatives, pharmacecctical compositions containg the same derivatives and their use |
| 01/18/2000 | US6015913 Heating cocoa beans to loosen shell without roasting nib, winnowing nibs from shells, screw pressing nibs to produce cocoa butter and partially defatted cocoa solids |
| 01/18/2000 | US6015912 Treating arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 01/18/2000 | US6015893 Oligonucleoside compounds and methods for inhibiting tumor growth, invasion and metastasis |
| 01/18/2000 | US6015892 Nucleotide sequences for diagnosis and treatment of related disorders; antisense/anticarcinogenic/antitumor agents; antiinflammatory/antiproliferative agents |
| 01/18/2000 | US6015883 Amino acid sequence of purified chemokine polypeptide; treatment of immune deficiency diseases, autoimmune diseases, allergies or asthma; anticarcinogenic/antiinflammatory/ antiarthritic agents |
| 01/18/2000 | US6015878 Antitumor agents isolated from intestinal mucosa, a method for their isolation and their application |
| 01/18/2000 | US6015827 Benzoxazole-4-carboxamides and their use in inhibiting poly (adp-ribose) polymerase activity and improving cytotoxic effectiveness of cytotoxic drugs or radiotherapy |
| 01/18/2000 | US6015814 Quinazoline derivative |
| 01/18/2000 | US6015811 Antitumor Chrysene derivatives |
| 01/18/2000 | US6015805 Potent antiprogestational activity and are useful in the treatment of fibroids, endometriosis, cervical ripening prior to delivery, hormone replacement therapy and in the control of fertility. |
| 01/18/2000 | US6015804 Method of using tetracycline compounds to enhance interleukin-10 production |
| 01/18/2000 | US6015798 Mixture of omega-3 polyunsaturated fatty acids and arginine, cats and dogs |
| 01/18/2000 | US6015712 Antisense modulation of FADD expression |
| 01/18/2000 | US6015710 Specific nucleobase sequences; for administration to mammalian cells in vitro |
| 01/18/2000 | US6015702 Nucleotide and amino acid sequences; for diagnosis, prevention and treatment of neoplastic, developmental, immune and nervous system disorders; anticarcinogenic/antitumor/ antisense agents |
| 01/18/2000 | US6015695 Immunoglobulins devoid of light chains |
| 01/18/2000 | US6015680 Human lung adenocarcinoma-related monoclonal antibody and immunoassay method which uses the same |
| 01/18/2000 | US6015578 Trapidil for use in the therapy of syndrome that may be influenced by immunomodulators |
| 01/18/2000 | US6015569 Polycyclic aromatic compounds and pharmaceutical/cosmetic compositions comprised thereof |
| 01/18/2000 | US6015562 Antitumor agents |
| 01/18/2000 | US6015561 Antigen binding peptides (abtides) from peptide libraries |
| 01/18/2000 | US6015556 Cytotoxic drug therapy |
| 01/18/2000 | US6015543 Diagnosis of tumors |
| 01/18/2000 | US6015541 Radioactive embolizing compositions |
| 01/18/2000 | CA2142277C Anti-cancer therapeutic compositions for prophylaxis or for treatment of cancer |
| 01/18/2000 | CA2113871C A strain of streptomyces lavendofoliae dkrs and a method for producing aclacinomycins a,b,y and aglycones using the same |
| 01/13/2000 | WO2000002051A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000002050A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | WO2000001851A1 Antisense oligonucleotides targeted to il-15 |
| 01/13/2000 | WO2000001822A1 Specific binding proteins including antibodies which bind to the necrotic centre of tumours, and uses thereof |
| 01/13/2000 | WO2000001821A2 Neurotransmission associated proteins |
| 01/13/2000 | WO2000001730A1 Peptides based on the sequence of human lactoferrin and their use |
| 01/13/2000 | WO2000001728A1 Galectin 11 |
| 01/13/2000 | WO2000001713A2 Diacylglycerol acyl transferase proteins |
| 01/13/2000 | WO2000001706A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace) |
| 01/13/2000 | WO2000001702A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001701A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001699A1 Novel indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
| 01/13/2000 | WO2000001676A1 Potassium channel blocking agents |
| 01/13/2000 | WO2000001668A2 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 01/13/2000 | WO2000001419A1 Drug complex for treatment of metastatic prostate cancer |
| 01/13/2000 | WO2000001418A1 Transgene expression in polarized cells |
| 01/13/2000 | WO2000001417A1 Delivery system |
| 01/13/2000 | WO2000001411A1 Farnesyl protein transferase inhibitors with in vivo radiosensitizing properties |
| 01/13/2000 | WO2000001393A2 OLIGONUCLEOTIDE INHIBITORS OF bcl-xL |
| 01/13/2000 | WO2000001389A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/13/2000 | WO2000001383A1 Angiogenesis inhibitors |
| 01/13/2000 | WO2000001382A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | WO2000001380A1 cyclo-oxygenase inhibitor |
| 01/13/2000 | WO2000001366A1 A method of administering liposomal encapsulated taxane |
| 01/13/2000 | WO1999059628A3 Combination therapy for the treatment of tumors |
| 01/13/2000 | WO1999058534A3 Epothilone derivatives, a method for the production thereof, and their use |
| 01/13/2000 | WO1999053953A3 Methods and products related to metabolic interactions in disease |
| 01/13/2000 | WO1999051259A3 Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines |
| 01/13/2000 | DE19822985C1 Tumorsuppressorgene der p53-Familie Tumor suppressor p53 family |
| 01/13/2000 | CA2658200A1 Naaladase inhibitors useful as pharmaceutical compounds and compositions |
| 01/13/2000 | CA2402839A1 Galectin 11 |
| 01/13/2000 | CA2337794A1 Transgene expression in polarized cells |
| 01/13/2000 | CA2336774A1 Angiogenesis inhibitors |
| 01/13/2000 | CA2336739A1 Trifunctional reagent for conjugation to a biomolecule |
| 01/13/2000 | CA2336714A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 01/13/2000 | CA2336475A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2336448A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2336419A1 Novel indolocarbazole derivatives useful for the treatment of neurodegenerative diseases and cancer |
| 01/13/2000 | CA2336406A1 Galectin 11 |
| 01/13/2000 | CA2336384A1 Oligonucleotide inhibitors of bcl-xl |
| 01/13/2000 | CA2336054A1 Inhibitors of prenyl-protein transferase |
| 01/13/2000 | CA2335918A1 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ace) |
| 01/13/2000 | CA2332699A1 Antisense oligonucleotides targeted to il-15 |
| 01/13/2000 | CA2332309A1 Neurotransmission associated proteins |
| 01/12/2000 | EP0970950A2 Novel isoxazoline and isoxazole fibrinogen receptor antagonists |
| 01/12/2000 | EP0970227A1 Recombinant antibodies and immunoconjugates targeted to cd-22 bearing cells and tumors |
| 01/12/2000 | EP0970217A2 Anti-alpha-v beta-3 recombinant humanized antibodies, nucleic acids encoding same and methods of use |
| 01/12/2000 | EP0970215A1 Suppressor of cytokine signaling |
| 01/12/2000 | EP0970213A2 Death domain containing receptor 5 |
| 01/12/2000 | EP0970208A1 Sp$g(a): A SCAVENGER RECEPTOR CYSTEINE-RICH DOMAIN-CONTAINING POLYPEPTIDE, AND MONOCLONAL ANTIBODIES THERETO |
| 01/12/2000 | EP0970187A1 Pituitary differentiation factor and methods of use thereof |
| 01/12/2000 | EP0970128A1 Immunotherapeutic ctla-4 binding peptides |
| 01/12/2000 | EP0970126A2 Method for the production of antihuman antigen receptors and uses thereof |
| 01/12/2000 | EP0970125A2 Histidine decarboxylase immunoreactivity to detect cancer |
| 01/12/2000 | EP0970122A1 Human anion channel |
| 01/12/2000 | EP0970120A2 Compositions and methods for diagnosing/treating disease based on beta-catenin/transcription factor interactions |
| 01/12/2000 | EP0970116A1 Method of cell inhibition using polypeptides derived from the venom of the austrialian jumper ant myrmecia pilosula |
| 01/12/2000 | EP0970111A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970109A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970108A2 Secreted proteins and polynucleotides encoding them |
| 01/12/2000 | EP0970104A2 Steroid sulfamates, method for the production and use thereof |
| 01/12/2000 | EP0970098A1 Anthracycline glycosides |
| 01/12/2000 | EP0970084A1 Pyrrolo 2,3d]pyrimidines and their use as tyrosine kinase inhibitors |
| 01/12/2000 | EP0970070A1 Phthalazines with angiogenesis inhibiting activity |
| 01/12/2000 | EP0970056A1 Substituted 2-anilinopyrimidines useful as protein kinase inhibitors |
| 01/12/2000 | EP0970046A1 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 01/12/2000 | EP0969877A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections |